Halogenoderma Publications

Clinical Trial Review Systematic Review Meta-Analysis Books and Documents Randomized Controlled Trial

8 results match your criteria: "Halogenoderma"

J Cutan Pathol

September 2023

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

* A case involving a 78-year-old patient revealed a skin rash following iodinated contrast administration, with significant symptoms noted soon after.
* A biopsy performed within 24 hours showed specific histological features resembling cryptococcal infection, suggesting that early diagnosis of iododerma is possible.

Cureus

November 2022

Dermatology, King Abdulaziz Hospital, Makkah, SAU.

Halogenoderma (HD) is a rare skin condition caused by exposure to halogen substances like iodide and bromide; it can manifest as iododerma or bromoderma.
A 40-year-old male developed itchy skin lesions, low-grade fever, and malaise after taking food supplements containing iodide and bromide for four months.
A skin biopsy revealed significant inflammation and abscess formation, but the lesions completely resolved after the patient stopped using the supplements and applied topical corticosteroids.

Contact Dermatitis

February 2022

Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, Yonago, Japan.

JAAD Case Rep

April 2020

Department of Dermatology, University of Michigan, Ann Arbor, Michigan.

Cutis

April 2004

* The lesions can grow quite large, making treatment options complicated and sometimes ineffective.
* A case study highlights a patient with KACM, showing that while treatments like imiquimod and methotrexate didn't work, the 5-fluorouracil cream was successful in treating the lesions.